Drug Hepatotoxicity,An Issue of Clinics in Liver Disease
Seiten
2019
Elsevier - Health Sciences Division (Verlag)
978-0-323-70857-9 (ISBN)
Elsevier - Health Sciences Division (Verlag)
978-0-323-70857-9 (ISBN)
In collaboration with Consulting Editor, Dr. Norman Gitlin, Dr. Pierre Gholam has put together topics that provide a current clinical update on the treatment and management of patients with drug-induced liver injury (DILI). Expert authors have contributed clinical review articles on the following topics: Epidemiology, Predisposing Factors and Outcomes; Genetic Predisposition to DILI; Causality Assessment Frequent Offenders and Patterns of Injury; Quantitative Systems Toxicology Approaches to Understand and Predict DILI; Liver Histology: Diagnostic and Prognostic Features; Acute Liver Failure Secondary to DILI; DILI in Persons with Pre-existing Chronic Liver Disease; DILI in the Setting of Statin Use; DILI in the Setting of Analgesic Use; DILI Secondary to Herbals and Dietary Supplements; and DILI Reporting and Resources for the Clinician. Readers will come away with the information they need to improve outcomes in patients with DILI.
Erscheinungsdatum | 26.11.2019 |
---|---|
Reihe/Serie | The Clinics: Internal Medicine |
Verlagsort | Philadelphia |
Sprache | englisch |
Maße | 152 x 229 mm |
Gewicht | 390 g |
Themenwelt | Medizinische Fachgebiete ► Innere Medizin ► Gastroenterologie |
ISBN-10 | 0-323-70857-9 / 0323708579 |
ISBN-13 | 978-0-323-70857-9 / 9780323708579 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
Buch | Softcover (2024)
Urban & Fischer in Elsevier (Verlag)
59,00 €